DGS vs. CURE
DGS (WisdomTree Emerging Markets SmallCap Dividend Fund) and CURE (Direxion Daily Healthcare Bull 3x Shares) are both exchange-traded funds - DGS is a Emerging Markets Diversified fund tracking the WisdomTree Emerging Markets SmallCap Dividend Index, while CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%). Both are passively managed. Over the past 10 years, DGS returned 10.14%/yr vs 13.49%/yr for CURE. At a 0.48 correlation, their price movements are largely independent. DGS charges 0.58%/yr vs 1.08%/yr for CURE.
Performance
DGS vs. CURE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DGS achieves a 14.94% return, which is significantly higher than CURE's -7.96% return. Over the past 10 years, DGS has underperformed CURE with an annualized return of 10.14%, while CURE has yielded a comparatively higher 13.49% annualized return.
DGS
- 1D
- 0.65%
- 1M
- 1.51%
- YTD
- 14.94%
- 6M
- 17.07%
- 1Y
- 25.61%
- 3Y*
- 15.36%
- 5Y*
- 8.06%
- 10Y*
- 10.14%
CURE
- 1D
- -0.55%
- 1M
- 13.71%
- YTD
- -7.96%
- 6M
- -6.00%
- 1Y
- 28.51%
- 3Y*
- 3.05%
- 5Y*
- 1.51%
- 10Y*
- 13.49%
DGS vs. CURE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
DGS WisdomTree Emerging Markets SmallCap Dividend Fund | 14.94% | 21.18% | 1.13% | 19.08% | -12.35% | 15.33% | 4.06% | 18.90% | -16.52% | 37.47% |
CURE Direxion Daily Healthcare Bull 3x Shares | -7.96% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
Correlation
The correlation between DGS and CURE is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.32 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.32 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.38 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.44 |
Correlation (All Time) Calculated using the full available price history since Jun 15, 2011 | 0.48 |
The correlation between DGS and CURE shifts across timeframes, from 0.32 (3 years) to 0.48 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DGS vs. CURE — Risk / Return Rank
DGS
CURE
DGS vs. CURE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for WisdomTree Emerging Markets SmallCap Dividend Fund (DGS) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DGS | CURE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.84 | ||
| Sortino ratioReturn per unit of downside risk | +0.84 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.13 | +0.14 |
| Calmar ratioReturn relative to maximum drawdown | 2.38 | 0.85 | +1.52 |
| Martin ratioReturn relative to average drawdown | 7.84 | 1.94 | +5.90 |
Loading charts...
Drawdowns
DGS vs. CURE - Drawdown Comparison
The maximum DGS drawdown since its inception was -61.83%, smaller than the maximum CURE drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for DGS and CURE.
Loading charts...
Drawdown Indicators
| DGS | CURE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -61.83% | -69.19% | +7.36% |
Max Drawdown (1Y)Largest decline over 1 year | -10.06% | -31.10% | +21.04% |
Max Drawdown (3Y)Largest decline over 3 years | -19.31% | -51.93% | +32.62% |
Max Drawdown (5Y)Largest decline over 5 years | -24.86% | -52.23% | +27.37% |
Max Drawdown (10Y)Largest decline over 10 years | -44.08% | -69.19% | +25.11% |
Current DrawdownCurrent decline from peak | -1.05% | -26.94% | +25.89% |
Average DrawdownAverage peak-to-trough decline | -12.57% | -18.16% | +5.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.05% | 13.71% | -10.66% |
Volatility
DGS vs. CURE - Volatility Comparison
The current volatility for WisdomTree Emerging Markets SmallCap Dividend Fund (DGS) is 7.30%, while Direxion Daily Healthcare Bull 3x Shares (CURE) has a volatility of 14.30%. This indicates that DGS experiences smaller price fluctuations and is considered to be less risky than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DGS | CURE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.30% | 14.30% | -7.00% |
Volatility (6M)Calculated over the trailing 6-month period | 14.27% | 30.87% | -16.60% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.60% | 44.32% | -27.72% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.08% | 43.84% | -28.76% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.39% | 49.59% | -32.20% |
DGS vs. CURE - Expense Ratio Comparison
DGS has a 0.58% expense ratio, which is lower than CURE's 1.08% expense ratio.
Dividends
DGS vs. CURE - Dividend Comparison
DGS's dividend yield for the trailing twelve months is around 3.20%, more than CURE's 1.16% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.16% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% | 0.00% | 0.00% |
DGS WisdomTree Emerging Markets SmallCap Dividend Fund | 3.20% | 3.45% | 3.36% | 4.55% | 5.34% | 3.98% | 3.69% | 3.95% | 4.24% | 2.81% | 3.42% | 3.28% |
Frequently Asked Questions
DGS and CURE have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CURE has higher volatility (14.30%) compared to DGS (7.30%). In terms of maximum drawdown, DGS dropped -61.83% vs CURE's -69.19%.
On 10-year performance, CURE leads with 13.49% vs 10.14% for DGS. On fees, DGS is cheaper at 0.58% per year. On volatility, DGS has been the lower-risk option at 7.30%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, CURE has performed better with a 13.49% return vs 10.14%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
DGS is cheaper with a 0.58% expense ratio, compared with 1.08% for CURE.
DGS has the higher dividend yield at 3.20%, compared with 1.16% for CURE.
DGS is categorized as Emerging Markets Diversified, while CURE is Leveraged Equities. DGS tracks WisdomTree Emerging Markets SmallCap Dividend Index, while CURE tracks Health Care Select Sector Index (300%). They also come from different issuers: WisdomTree and Direxion. Their fees differ too: 0.58% for DGS and 1.08% for CURE.
DGS currently has the higher Sharpe Ratio (1.44 vs 0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DGS and CURE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer